Outcome measures reported by cancer patients treated with tyrosine kinase inhibitors: a methodological study.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-01-01
DOI
https://doi.org/10.1590/0034-7167-2024-0018
Primary Topic
Healthcare during COVID-19 Pandemic
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outcome measures reported by cancer patients treated with tyrosine kinase inhibitors: a methodological study.

Julie Ponto, Ana Maria Teixeira Pires, Edvane Birelo Lopes De Domenico, Eliana Cavalari Teraoka et al.
PubMed
Healthcare during COVID-19 Pandemic
article

Outcome measures reported by cancer patients treated with tyrosine kinase inhibitors: a methodological study.

Julie Ponto, Ana Maria Teixeira Pires, Edvane Birelo Lopes De Domenico, Eliana Cavalari Teraoka, Fabio Rodrigues Kerbauy
article en

Abstract

No abstract available for this paper.
PubMedVol. 78(2)
Universidade Federal de São Paulo (BR)
Openalex Percentile: Top 92%
Healthcare during COVID-19 Pandemic
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Outcome measures reported by cancer patients treated with tyrosine kinase inhibitors: a methodological study. — Julie Ponto, Ana Maria Teixeira Pires, et al. · PubMed (2025) | TGRS Research Map | TGRS